Siren LLC’s ADARx Pharmaceuticals, Inc. Common Stock ADRX Stock Holding History

Siren LLC’s Portfolio ADRX Stock Details ADRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$38.4M	Buy	+1,925,794	New	+$38.5M	0.91%	31

Other funds holding ADRX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

Landscape Capital Management Englewood, New Jersey $1.34B AUM 18.69% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Siren LLC's ADRX Position: Q3 2026 in Review

Siren LLC opened a new position in ADARx Pharmaceuticals, Inc. Common Stock (ADRX) in Q3 2026: 1,925,794 shares worth $38.4M. The stake represents 0.91% of the portfolio and ranks #31 among its holdings.

14 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

Siren LLC held 1,925,794 shares of ADARx Pharmaceuticals, Inc. Common Stock worth $38.4M as of Q3 2026.
ADARx Pharmaceuticals, Inc. Common Stock was a new Siren LLC position in Q3 2026.
ADARx Pharmaceuticals, Inc. Common Stock made up 0.91% of Siren LLC's portfolio in Q3 2026, its #31 holding.
14 funds tracked by Wall St. Rank held ADARx Pharmaceuticals, Inc. Common Stock as of Q3 2026.

Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.